Rashtriya Newsflash

Primary Sclerosing Cholangitis Drugs in Development 2026: Pipeline Therapies, Ongoing Trials, and Companies Driving Innovation | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics, Cascade Pharma

Primary Sclerosing Cholangitis Drugs in Development 2026: Pipeline Therapies, Ongoing Trials, and Companies Driving Innovation | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics, Cascade Pharma

(Albany, New York) – November 13, 2026: As per DelveInsight’s assessment, globally, Primary Sclerosing Cholangitis pipeline constitutes 14+ key companies continuously working towards developing 14+ Primary Sclerosing Cholangitis treatment therapies,

Read Full Article

Osteoporosis Market on the Rise: Growth Opportunities, Challenges, and Future Outlook Through 2036 | Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine

The Key Osteoporosis Companies in the market include – Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine, Levolta Pharmaceuticals, Inc., Celltrion, Teva Pharmaceuticals, and others.  

Read Full Article

Taxi Market Size to Reach USD 366.91 Billion by 2031, Driven by Urban Mobility Demand and Digital Ride-Hailing Services – Mordor Intelligence

Taxi Market Mordor Intelligence has published a new report on the Taxi Market offering a comprehensive analysis of trends, growth drivers, and future projections. Hyderabad, India, November 12, 2026 – According

Read Full Article

Rice Flour Market Size Set to Reach $2.12 Billion by 2031 Driven by Ultra-Fine Milling and Commercial Bakery Adoption – Mordor Intelligence

Rice Flour Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the rice flour market, offering a comprehensive analysis of market trends, growth drivers,

Read Full Article

Hypertrophic Cardiomyopathy Pipeline Insights 2026: Novel Mechanisms, Promising Candidates, and Competitive Landscape | Tenaya Therapeutics, Shandong Suncadia Medicine, MyoKardia, Imbria Pharma

(Albany, New York) – November 12, 2026: As per DelveInsight’s assessment, globally, Hypertrophic Cardiomyopathy pipeline constitutes 10+ key companies continuously

Read Full Article

Neuroendocrine Tumors Clinical Trials Update 2026: Phase-Wise Pipeline Status, Drug Profiles, and Key Developers | Camurus, Orano Med, Vyriad, Pfizer, Takeda Oncology, Hutchison MediPharma, Provectus

(Albany, New York) – November 12, 2026: As per DelveInsight’s assessment, globally, Neuroendocrine Tumors pipeline constitutes 115+ key companies continuously

Read Full Article

FG Communities Holdings Announces Third Quarter 2026 Financial Results and Provides Update on Execution of Real Estate Strategy

Company Invests $10 Million in FG Communities, Inc., Completes First Two Direct Manufactured Housing Acquisitions and Ends Third Quarter with

Read Full Article

Dreams as Divine Messages Marty Tilley Shares Her Prophetic Journey in Grasping for Spiritual Sight with Kate Delaney on Global Book Network

The Tennessee author reveals how a series of vivid, unsettling dreams opened her eyes to the ways God still speaks

Read Full Article

SenesTech Reports Record Q3 2026 Revenue with 59% Year-Over-Year Growth

SURPRISE, Ariz. – November 12, 2026 – SenesTech, Inc. (NASDAQ: SNES), an innovator in rodent control, today announced financial results for

Read Full Article

Euclid telescope data will prove that fourth space dimension exists, and will force a paradigm shift in science

Euclid Data (DR1 Foundation) will be publicly released on November 12, 2026. A plot of number of galaxies vs. their

Read Full Article